Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Year in Review
  • Published:

Multiple sclerosis in 2017

Progress in multiple sclerosis — from diagnosis to therapy

Nature Reviews Neurology volume 14, pages 72–74 (2018)Cite this article

Subjects

An Author Correction to this article was published on 01 April 2019

In 2017, extensive research into multiple sclerosis (MS) resulted in improved diagnostic criteria, development of biomarkers that enable monitoring of disease evolution and treatment response over time, and identification of novel genetic markers of disease susceptibility. In addition, 2017 saw the first successful clinical trials of remyelination strategies and treatments for progressive MS.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Thompson, A. J. et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 17, 162–173 (2018).

    Article  Google Scholar 

  2. Solomon, A. J. & Corboy J. R. The tension between early diagnosis and misdiagnosis in multiple sclerosis. Nat. Rev. Neurol. 13, 567–572 (2017).

    Article  Google Scholar 

  3. Filippi, M. et al. MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines. Lancet Neurol. 15, 292–303 (2016).

    Article  Google Scholar 

  4. Novakova, L. et al. Cerebrospinal fluid biomarkers as a measure of disease activity and treatment efficacy in relapsing-remitting multiple sclerosis. J. Neurochem. 141, 296–304 (2017).

    Article  CAS  Google Scholar 

  5. Disanto, G. et al. Serum neurofilament light: a biomarker of neuronal damage in multiple sclerosis. Ann. Neurol. 81, 857–870 (2017).

    Article  CAS  Google Scholar 

  6. Steri, M. et al. Overexpression of the cytokine BAFF and autoimmunity risk. N. Engl. J. Med. 376, 1615–1626 (2017).

    Article  CAS  Google Scholar 

  7. Montalban, X. et al. Ocrelizumab versus placebo in primary progressive multiple sclerosis. N. Engl. J. Med. 376, 209–220 (2017).

    Article  CAS  Google Scholar 

  8. Hawker, K. et al. Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial. Ann. Neurol. 66, 460–471 (2009).

    Article  CAS  Google Scholar 

  9. Green, A. J. et al. Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial. Lancet 390, 2481–2489 (2017).

    Article  CAS  Google Scholar 

  10. Ontaneda, D., Cohen, J. A. & Amato, M. P. Clinical outcome measures for progressive MS trials. Mult. Scler. 23, 1627–1635 (2017).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari, Italy

    Maria Trojano

  2. Department NEUROFARBA, Section Neurosciences, University of Florence, Italy

    Maria Pia Amato

Authors
  1. Maria Trojano
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maria Pia Amato
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

The authors contributed equally to the preparation of the manuscript.

Corresponding author

Correspondence to Maria Trojano.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Trojano, M., Amato, M. Progress in multiple sclerosis — from diagnosis to therapy. Nat Rev Neurol 14, 72–74 (2018). https://doi.org/10.1038/nrneurol.2018.3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneurol.2018.3

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing